DK165326C - Monoklonale antistoffer mod humanrenin og derivater deraf samt fremgangsmaade til deres fremstilling, hybridoma-cellelinier samt fremgangsmaade til deres fremstilling, anvendelse af de monoklonale antistoffer og deres derivater samt testsaet indeholdende antistofferne og/eller deres derivater - Google Patents

Monoklonale antistoffer mod humanrenin og derivater deraf samt fremgangsmaade til deres fremstilling, hybridoma-cellelinier samt fremgangsmaade til deres fremstilling, anvendelse af de monoklonale antistoffer og deres derivater samt testsaet indeholdende antistofferne og/eller deres derivater

Info

Publication number
DK165326C
DK165326C DK153385A DK153385A DK165326C DK 165326 C DK165326 C DK 165326C DK 153385 A DK153385 A DK 153385A DK 153385 A DK153385 A DK 153385A DK 165326 C DK165326 C DK 165326C
Authority
DK
Denmark
Prior art keywords
antist
derivatives
preparation
monoclonal antibodies
cell lines
Prior art date
Application number
DK153385A
Other languages
English (en)
Other versions
DK165326B (da
DK153385D0 (da
DK153385A (da
Inventor
Christoph Heusser
Rudolf Heinrich Andreatta
Sefik Alkan
Jeanette Wood
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK153385D0 publication Critical patent/DK153385D0/da
Publication of DK153385A publication Critical patent/DK153385A/da
Publication of DK165326B publication Critical patent/DK165326B/da
Application granted granted Critical
Publication of DK165326C publication Critical patent/DK165326C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
DK153385A 1984-04-09 1985-04-03 Monoklonale antistoffer mod humanrenin og derivater deraf samt fremgangsmaade til deres fremstilling, hybridoma-cellelinier samt fremgangsmaade til deres fremstilling, anvendelse af de monoklonale antistoffer og deres derivater samt testsaet indeholdende antistofferne og/eller deres derivater DK165326C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH178184 1984-04-09
CH178184 1984-04-09

Publications (4)

Publication Number Publication Date
DK153385D0 DK153385D0 (da) 1985-04-03
DK153385A DK153385A (da) 1985-10-10
DK165326B DK165326B (da) 1992-11-09
DK165326C true DK165326C (da) 1993-03-29

Family

ID=4218460

Family Applications (1)

Application Number Title Priority Date Filing Date
DK153385A DK165326C (da) 1984-04-09 1985-04-03 Monoklonale antistoffer mod humanrenin og derivater deraf samt fremgangsmaade til deres fremstilling, hybridoma-cellelinier samt fremgangsmaade til deres fremstilling, anvendelse af de monoklonale antistoffer og deres derivater samt testsaet indeholdende antistofferne og/eller deres derivater

Country Status (13)

Country Link
US (1) US4780401A (da)
EP (1) EP0158599B1 (da)
JP (2) JPH0669390B2 (da)
AT (1) ATE57392T1 (da)
AU (1) AU591870B2 (da)
CA (1) CA1277261C (da)
DE (1) DE3580056D1 (da)
DK (1) DK165326C (da)
ES (2) ES8707295A1 (da)
FI (1) FI87933C (da)
IE (1) IE57956B1 (da)
NO (1) NO165556C (da)
ZA (1) ZA852557B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972990A (en) * 1992-04-10 1999-10-26 Brigham And Women's Hospital, Inc. Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
AU4250893A (en) * 1992-05-14 1993-12-13 L.R.S. Diagnostics, Inc. Methods and novel proteins associated with low renin syndrome
EP0606516B1 (en) * 1993-01-13 1998-12-30 Idemitsu Kosan Company Limited Anti-human ceruloplasmin monoclonal antibody
WO1994020857A1 (en) * 1993-03-11 1994-09-15 The Regents Of The University Of California Assay for humoral immunity to macromolecules
US6911528B1 (en) * 1994-12-02 2005-06-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US20030167483A1 (en) * 1998-06-24 2003-09-04 Farese Robert V. Diacylglycerol O-acyltransferase
ES2375268T3 (es) 2000-12-14 2012-02-28 The Brigham And Women's Hospital, Inc. Marcadores inflamatorios para la detección y prevención de diabetes mellitus.
EP3072978B1 (en) 2002-05-09 2018-07-11 The Brigham and Women's Hospital, Inc. 1l1rl-1 as a cardiovascular disease marker
US7273616B2 (en) * 2002-05-10 2007-09-25 The Trustees Of Columbia University In The City Of New York Genetically engineered cell lines and systems for propagating Varicella zoster virus and methods of use thereof
US20070010571A1 (en) * 2003-08-20 2007-01-11 Nitromed, Inc. Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
AU2004270162B2 (en) * 2003-08-28 2010-05-13 Nicox S.A. Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
AU2004315596B2 (en) 2003-08-29 2011-11-24 President And Fellows Of Harvard College Inhibitors of cellular necrosis
ATE546734T1 (de) 2003-12-05 2012-03-15 Cleveland Clinic Foundation Risikomarker für eine herzkreislaufkrankheit
US20090131342A1 (en) * 2004-01-22 2009-05-21 Nitromed, Inc. Nitrosated and/or nitrosylated compounds, compositions and methods of use
US7803838B2 (en) * 2004-06-04 2010-09-28 Forest Laboratories Holdings Limited Compositions comprising nebivolol
WO2006041855A2 (en) 2004-10-04 2006-04-20 Nitromed, Inc. Compositions and methods using apocynin compounds and nitric oxide donors
US9164104B2 (en) 2004-10-06 2015-10-20 The Brigham And Women's Hospital, Inc. Relevance of achieved levels of markers of systemic inflammation following treatment
JP2008520578A (ja) * 2004-11-15 2008-06-19 ニトロメッド インコーポレーティッド 複素環式の酸化窒素供与体基を含む利尿化合物、組成物および使用方法
WO2006078995A1 (en) * 2005-01-21 2006-07-27 Nitromed, Inc. Cardiovascular compounds comprising heterocyclic nitric oxide donor group compositions and methods of use
JP2008528626A (ja) * 2005-01-31 2008-07-31 マイラン ラボラトリーズ インク． ヒドロキシル化されたネビボロールを含む薬学的組成物
WO2007086884A2 (en) * 2005-02-16 2007-08-02 Nitromed, Inc. Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use
US20090012057A1 (en) * 2005-02-28 2009-01-08 Nitromed, Inc. Cardiovascular Compounds Comprising Nitric Oxide Enhancing Groups, Compositions and Methods of Use
WO2006099058A2 (en) * 2005-03-09 2006-09-21 Nitromed, Inc. Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use
EP1982711A1 (en) 2005-05-31 2008-10-22 Mylan Laboratories, Inc Compositions comprsing nebivolol
US20090018091A1 (en) * 2005-08-02 2009-01-15 Nitromed, Inc. Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use
CA2624933A1 (en) * 2005-10-04 2007-04-12 Nitromed, Inc. Methods for treating respiratory disorders
US8119358B2 (en) 2005-10-11 2012-02-21 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
EP1954685A4 (en) * 2005-11-16 2009-11-11 Nitromed Inc FUROXANE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
WO2007075541A2 (en) * 2005-12-20 2007-07-05 Nitromed, Inc. Nitric oxide enhancing glutamic acid compounds, compositions and methods of use
US20080293702A1 (en) * 2005-12-22 2008-11-27 Nitromed, Inc. Nitric Oxide Enhancing Pyruvate Compounds, Compositions and Methods of Use
US20080057590A1 (en) 2006-06-07 2008-03-06 Mickey Urdea Markers associated with arteriovascular events and methods of use thereof
US7897360B2 (en) * 2006-12-15 2011-03-01 Kimberly-Clark Worldwide, Inc. Enzyme detection techniques
WO2008131224A2 (en) 2007-04-18 2008-10-30 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
US7828840B2 (en) * 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
GB2460915B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
EP2531163A1 (en) 2010-02-01 2012-12-12 The Hospital For Sick Children Remote ischemic conditioning for treatment and preventon of restenosis
CA2795053A1 (en) 2010-03-31 2011-10-06 The Hospital For Sick Children Use of remote ischemic conditioning to improve outcome after myocardial infarction
EP2855458B1 (en) 2012-05-11 2018-08-08 Reset Therapeutics, Inc. Carbazole-containing sulfonamides as cryptochrome modulators
ES2786506T3 (es) 2012-08-01 2020-10-13 Zahra Tavakoli Composiciones congeladas fluidas que comprenden un agente terapéutico
EP2968276A4 (en) 2013-03-15 2017-02-15 President and Fellows of Harvard College Hybrid necroptosis inhibitors
TWI690521B (zh) 2014-04-07 2020-04-11 美商同步製藥公司 作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
CN110114676B (zh) * 2016-10-21 2022-03-25 富士瑞必欧株式会社 肾素浓度的免疫学测定方法
CN107007849A (zh) * 2017-06-19 2017-08-04 河北省人民医院 一种建立甲减性心功能不全大鼠动物模型的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies

Also Published As

Publication number Publication date
IE57956B1 (en) 1993-05-19
AU591870B2 (en) 1989-12-21
DE3580056D1 (de) 1990-11-15
ES8707295A1 (es) 1987-07-16
CA1277261C (en) 1990-12-04
ZA852557B (en) 1985-11-27
ES542017A0 (es) 1987-07-16
US4780401A (en) 1988-10-25
EP0158599A2 (de) 1985-10-16
EP0158599B1 (de) 1990-10-10
DK165326B (da) 1992-11-09
EP0158599A3 (en) 1987-12-16
JPH0669390B2 (ja) 1994-09-07
DK153385D0 (da) 1985-04-03
JPS60231624A (ja) 1985-11-18
NO165556B (no) 1990-11-19
ES8802254A1 (es) 1988-04-16
NO851384L (no) 1985-10-10
FI851334L (fi) 1985-10-10
ES557016A0 (es) 1988-04-16
FI87933C (fi) 1993-03-10
DK153385A (da) 1985-10-10
AU4088685A (en) 1985-10-17
ATE57392T1 (de) 1990-10-15
FI851334A0 (fi) 1985-04-03
JPH0669371B2 (ja) 1994-09-07
IE850876L (en) 1985-10-09
JPS6485070A (en) 1989-03-30
FI87933B (fi) 1992-11-30
NO165556C (no) 1991-02-27

Similar Documents

Publication Publication Date Title
DK165326C (da) Monoklonale antistoffer mod humanrenin og derivater deraf samt fremgangsmaade til deres fremstilling, hybridoma-cellelinier samt fremgangsmaade til deres fremstilling, anvendelse af de monoklonale antistoffer og deres derivater samt testsaet indeholdende antistofferne og/eller deres derivater
DK572487D0 (da) Fremgangsmaade til fremstilling af human vaekstfaktor fra endotheliale celler
DK198883A (da) Fremgangsmaade til fremstilling af menneskevaevs-plasminogen-aktivator, dna-sekvens der koder for denne aktivator, replicerbar udtrykkelsesvektor for dna-sekvensen og mikroorganisme eller cellekultur transformeret med udtrykkelsesvektoren
DK590085A (da) Bicycliske heteroarylpiperazinderivater og fremgangsmaade til deres fremstilling
ES8307263A1 (es) Un procedimiento para la preparacion de fosfonamidas sustituidas.
NO852567L (no) Thymopentinanaloger og fremgangsmmaate for deres fremstilling.
DK162171C (da) Monoklonale antistoffer, der er reaktive med eimeriaarters sporozoitters antigener, og fremgangsmaade til deres fremstilling
DK98192A (da) Triphenylmethyl-derivater af sn-glycero-3-phosphocholin og sn-glycero-3-phosphoethanolamin og fremgangsmaade til fremstilling deraf
ES543391A0 (es) Procedimiento para la obtencion purificada de un factor de inhibicion de la emigracion de macrofagos humanos
ATE70310T1 (de) Verfahren zur herstellung von monoklonalen antikoerpern gegen hbsag.
DK12388A (da) Sialosylcholesterol, fremgangsmaade til fremstilling af og neuropatimiddel omfattende samme
SE8404334D0 (sv) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
DK299585A (da) Fremgangsmaade til behandling af syreholdige afgangsgasser
NO173831C (no) Nye monoklonale antistoffer mot IFN-omega, hybridomer til fremstilling derav og anvendelse for rensing samt paavisning eller kvantitativ bestemmelse av IFN-omega, og sett for bruk ved paavisningen
IT8267896A0 (it) Procedimento per la produzione del l aspartasi
DK380785D0 (da) S-6-fluor-4-aminochroman-4-carboxylsyre-forbindelser og salte deraf, fremgangsmaade til fremstilling deraf og anvendelse deraf til fremstilling af sorbinil
FI931988A (fi) Menetelmä terapeuttisesti aktiivisten fosfopeptidien valmistamiseksi
ATE78513T1 (de) Immunoglobulin-a-rezeptor-protein (arp), sowie dessen klonierung und expression.
DK45783D0 (da) Production and characterzation of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed